Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.76 |
| ▸ | MAPT | P10636 | 9/20 | 0.73 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.68 |
| ▸ | RAB9A | P51151 | 4/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | CASP3 | P42574 | 1/20 | 0.61 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.61 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.61 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 7/20 | 0.59 |
| ▸ | MEN1 | O00255 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8663226 | 1.00 | ABCG2 (0.76) | ABCG2MAPTHCAR2RAB9ANPC1 | |
| SCHEMBL11477087 | 0.90 | ABCG2 (0.77) | ABCG2MAPTHCAR2RAB9ANPC1 | |
| SCHEMBL11477089 | 0.90 | ABCG2 (0.77) | ABCG2MAPTHCAR2RAB9ANPC1 | |
| SCHEMBL17429547 | 0.86 | ABCG2 (1.00) | ABCG2MAPTHCAR2RAB9ANPC1 | |
| SCHEMBL28708176 | 0.86 | ABCG2 (1.00) | ABCG2MAPTHCAR2RAB9ANPC1 | |
| SCHEMBL3035766 | 0.85 | ABCG2 (0.74) | ABCG2MAPTHCAR2RAB9ANPC1 | |
| SCHEMBL31301136 | 0.85 | ABCG2 (0.74) | ABCG2MAPTHCAR2RAB9ANPC1 | |
| SCHEMBL7203615 | 0.85 | MAPT (1.00) | ABCG2MAPTHCAR2RAB9ANPC1 | |
| SCHEMBL7203616 | 0.85 | MAPT (1.00) | ABCG2MAPTHCAR2RAB9ANPC1 | |
| SCHEMBL3035768 | 0.85 | ABCG2 (0.74) | ABCG2MAPTHCAR2RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240261768-A1 | POLYNORBORNENE/CARBON BLACK-CROSS-LINKED THREE-DIMENSIONAL NETWORK-IMMOBILIZED COPPER/GOLD (PNBI/CB-Cu/Au) NANOCATALYST, AND PREPARATION METHOD AND USE THEREOF | Hubei Engineering University (CN) | 2024-08-08 | — | — | US | claimed |
| US-12576396-B2 | Polynorbornene/carbon black-cross-linked three-dimensional network-immobilized copper/gold (PNBI/CB-Cu/Au) nanocatalyst, and preparation method and use thereof | Hubei Engineering University (CN) | 2026-03-17 | — | — | US | disclosed |
| US-20240261768-A1 | POLYNORBORNENE/CARBON BLACK-CROSS-LINKED THREE-DIMENSIONAL NETWORK-IMMOBILIZED COPPER/GOLD (PNBI/CB-Cu/Au) NANOCATALYST, AND PREPARATION METHOD AND USE THEREOF | Hubei Engineering University (CN) | 2024-08-08 | — | — | US | disclosed |
| WO-2023206835-A1 | CROSS-LINKED NORBORNENE COPOLYMER/CARBON BLACK THREE-DIMENSIONAL NETWORK IMMOBILIZED BIMETALLIC COPPER/GOLD NANO-CATALYST, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 湖北工程学院 | 2023-11-02 | — | — | WO | disclosed |
| CN-111925324-B | Synthetic method of 3-acyl quinoline compound | 南通大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-111925324-A | Synthetic method of 3-acyl quinoline compound | 南通大学 | 2020-11-13 | — | — | CN | disclosed |
| US-20160145273-A1 | PRECATALYST FOR SHIBASAKI'S RARE EARTH METAL BINOLATE CATALYSTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2016-05-26 | — | — | US | disclosed |
| EP-1051910-A2 | The treatment of pests using certain ethylenically-unsaturated carbonyl compounds | Sorex Limited (GB) | 2000-11-15 | — | — | EP | disclosed |
| EP-0662968-B1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES INC (US) | 1998-12-02 | — | — | EP | disclosed |
| EP-0662968-A1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES, INC. (US) | 1995-07-19 | — | — | EP | disclosed |
| EP-0662968-A4 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS. | PPG INDUSTRIES INC (US) | 1995-04-12 | — | — | EP | disclosed |
| WO-1994007889-A1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES, INC. (US) | 1994-04-14 | — | — | WO | disclosed |
| US-5274132-A | Photochromic naphthopyran compounds | TRANSITIONS OPTICAL, INC. (US) | 1993-12-28 | — | — | US | disclosed |
| US-5037824-A | Cardiotonic, antiischemic agents | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| EP-0387070-A2 | N-Containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240261768-A1 | POLYNORBORNENE/CARBON BLACK-CROSS-LINKED THREE-DIMENSIONAL NETWORK-IMMOBILIZED COPPER/GOLD (PNBI/CB-Cu/Au) NANOCATALYST, AND PREPARATION METHOD AND USE THEREOF | AOC3, PNN, RPL23A | ABCG2 1186/4885MAPT 1563/4885HCAR2 3997/4885 |
| US-12576396-B2 | Polynorbornene/carbon black-cross-linked three-dimensional network-immobilized copper/gold (PNBI/CB-Cu/Au) nanocatalyst, and preparation method and use thereof | AOC3, PNN, SOD3 | ABCG2 1413/4885MAPT 1217/4885HCAR2 4204/4885 |
| US-20160145273-A1 | PRECATALYST FOR SHIBASAKI'S RARE EARTH METAL BINOLATE CATALYSTS | TBCB, RUVBL2, RHEB | ABCG2 3446/4885MAPT 1058/4885HCAR2 3506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.